To the Editor In his recent editorial, Dr Hayes correctly noted that "analytical validity and clinical utility" are needed for the adoption of a tumor biomarker test into clinical care. However, proving analytical validity with correlative or concordance studies is largely irrelevant without first proving clinical utility.
https://ift.tt/2L4UX1A
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Summary Insulinomas are rare neuroendocrine tumours that classically present with fasting hypoglycaemia. This case report discusses an un...
-
The online platform for Taylor & Francis Online content New for Canadian Journal of Remote Sen...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου